Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Customer input drives expansion of OGT’s Cytocell Aquarius® Haematology FISH probe range

Oxford Gene Technology
Posted on: 11 Oct 16

Oxford, UK – 11 October 2016. Oxford Gene Technology (OGT), The Molecular Genetics Company, has today announced a significant expansion of its existing catalogue of Cytocell Aquarius® Haematology probes for fluorescence in situ hybridisation (FISH) — underlining the company's position as the one-stop-shop for high-quality FISH probes. These additions have been introduced due to an ongoing commitment to use customer input as a major driver for the rapid development of the latest research-relevant probes. The 14 newly launched probes are:

 

  •          CBFB Proximal Probe Red
  •          CBFB Distal Probe Green
  •          MECOM Probe Red
  •          RUNX1 Probe Green
  •          NUP98 Proximal Probe Red
  •          NUP98 Distal Probe Green
  •          TET2 Probe Red
  •          USP46 (4q12) Probe Green
  •          CSF1R/RPS14 (5q32-q33) Probe Red
  •          EGR1/CDC25C (5q31) Probe Green
  •          TERT (5p15.33) Probe Aqua
  •          CUX1 (7q22) Probe Green
  •          EZH2 (7q36) Probe Red
  •          Chromosome 7 Alpha Satellite Probe Aqua

 

 


The new cost-effective and quality-assured probes are optimised for use on common sample types and are sold as pre-mixed, easy-to-use formulations to minimise experimental errors. The importance of researchers’ input in today’s announcement demonstrates the ongoing success of OGT’s myProbes® service, which enables scientists to order custom-made probes for virtually any sequence in the human genome. All probes are produced under GMP/GLP guidelines using the Cytocell BAC-2-FISH™ process, combining high-intensity signals with low levels of background fluorescence and providing maximum confidence in results.

As the longest-standing FISH probe manufacturer in the world, 2016 marks 25 years of Cytocell expertise and customer service in the development and production of FISH products. “myProbes gives us the opportunity to get continuous input from our customers,” explains Faidra Partheniou, Haematology Product Manager at OGT, “it truly helps us to respond quickly to changes in customer demand and it helps researchers by providing a first port of call for rapid development of new probes. These latest additions to our Cytocell Aquarius portfolio are testament to this.”

OGT also offers the opportunity to evaluate the accurate, user-friendly FISH probes in customer’s own labs free of charge by simply requesting up to four free probes from their extensive range. 

To find out more about the comprehensive range of Cytocell FISH probes and to request a free sample, please visit www.cytocell.com. You can also find out more at booth #1230 at the annual meeting of the American Society of Human Genetics (ASHG) in Montreal from 18 to 22 October.

The new additions to the Cytocell Aquarius® Haematology probe range are currently only available within North America as analyte specific reagents (ASRs), analytical and performance characteristics are not established. CE-marked IVD versions for sale in Europe are anticipated.

 

For further information, please contact:

Oxford Gene Technology, Begbroke Science Park, Begbroke Hill, Woodstock Road, Begbroke, Oxfordshire, OX5 1PF, U.K.

T: +44 (0) 1865 856826 ; F: +44 (0) 1865 848684

E: contact@ogt.com ; W: www.ogt.com ; Twitter: @OxfordGeneTech

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 11/10/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.